FR2627985A1 - Coadministration d'un medicament anti-inflammatoire non steroidique et de la sufotidine ou un de ses sels physiologiquement acceptables - Google Patents

Coadministration d'un medicament anti-inflammatoire non steroidique et de la sufotidine ou un de ses sels physiologiquement acceptables Download PDF

Info

Publication number
FR2627985A1
FR2627985A1 FR8902778A FR8902778A FR2627985A1 FR 2627985 A1 FR2627985 A1 FR 2627985A1 FR 8902778 A FR8902778 A FR 8902778A FR 8902778 A FR8902778 A FR 8902778A FR 2627985 A1 FR2627985 A1 FR 2627985A1
Authority
FR
France
Prior art keywords
sufotidine
pharmaceutical composition
piroxicam
steroidal
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR8902778A
Other languages
English (en)
French (fr)
Inventor
Roger Stables
Keith Thomas Bunce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FR2627985A1 publication Critical patent/FR2627985A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
FR8902778A 1988-03-04 1989-03-03 Coadministration d'un medicament anti-inflammatoire non steroidique et de la sufotidine ou un de ses sels physiologiquement acceptables Withdrawn FR2627985A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888805268A GB8805268D0 (en) 1988-03-04 1988-03-04 Medicaments

Publications (1)

Publication Number Publication Date
FR2627985A1 true FR2627985A1 (fr) 1989-09-08

Family

ID=10632893

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8902778A Withdrawn FR2627985A1 (fr) 1988-03-04 1989-03-03 Coadministration d'un medicament anti-inflammatoire non steroidique et de la sufotidine ou un de ses sels physiologiquement acceptables

Country Status (12)

Country Link
JP (1) JP2834175B2 (da)
KR (1) KR890014110A (da)
AU (1) AU3098489A (da)
BE (1) BE1002256A3 (da)
DE (1) DE3906884A1 (da)
DK (1) DK104489A (da)
FR (1) FR2627985A1 (da)
GB (2) GB8805268D0 (da)
IT (1) IT8947714A0 (da)
NL (1) NL8900525A (da)
SE (1) SE8900752L (da)
ZA (1) ZA891640B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO300260B1 (no) 1993-05-05 1997-05-05 Torgersen Hans & Soenn Bilbarnestol
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
CN1158994C (zh) * 1999-09-24 2004-07-28 爱尔康公司 含环丙沙星和地塞米松的局部悬浮制剂
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
CA2736547C (en) 2008-09-09 2016-11-01 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
MX2014007935A (es) 2011-12-28 2014-11-14 Pozen Inc Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2075007A (en) * 1980-02-28 1981-11-11 Glaxo Group Ltd Heterocyclic derivatives
FR2512343A1 (fr) * 1981-09-04 1983-03-11 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5- ( (3-( 3-1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique et procede de preparation de cette composition
GB2105193A (en) * 1981-09-04 1983-03-23 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
WO1988008302A1 (en) * 1987-04-24 1988-11-03 Abraham Sunshine Cough/cold mixtures comprising non-sedating antihistamine drugs

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2075007A (en) * 1980-02-28 1981-11-11 Glaxo Group Ltd Heterocyclic derivatives
FR2512343A1 (fr) * 1981-09-04 1983-03-11 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5- ( (3-( 3-1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique et procede de preparation de cette composition
GB2105193A (en) * 1981-09-04 1983-03-23 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
WO1988008302A1 (en) * 1987-04-24 1988-11-03 Abraham Sunshine Cough/cold mixtures comprising non-sedating antihistamine drugs

Also Published As

Publication number Publication date
AU3098489A (en) 1989-09-07
GB8805268D0 (en) 1988-04-07
GB2216413A (en) 1989-10-11
KR890014110A (ko) 1989-10-21
GB8904879D0 (en) 1989-04-12
IT8947714A0 (it) 1989-03-03
SE8900752L (sv) 1989-09-05
DE3906884A1 (de) 1989-09-14
DK104489D0 (da) 1989-03-03
NL8900525A (nl) 1989-10-02
JP2834175B2 (ja) 1998-12-09
BE1002256A3 (fr) 1990-11-06
DK104489A (da) 1989-09-05
SE8900752D0 (sv) 1989-03-03
JPH01316319A (ja) 1989-12-21
ZA891640B (en) 1990-03-28

Similar Documents

Publication Publication Date Title
TW580385B (en) Pharmaceutical composition for reducing insulin resistance in humans in whom impaired glucose tolerance and non-insulin dependent diabetes mellitus have not presented
RU2207850C2 (ru) Фармацевтическая композиция, содержащая в комбинации метформин и фибрат, и ее применение при приготовлении лекарственных средств, предназначенных для снижения гипергликемии
CN1102388C (zh) 用羟基咔唑化合物抑制平滑肌的移行与增生
BE1007268A3 (fr) Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie.
JP2010006830A (ja) 抗下痢剤およびエポチロンまたはエポチロン誘導体を含む組合せ剤
FR2673538A1 (fr) Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale.
SK9492000A3 (en) Pharmaceutical composition containing sibutramine and orlistat
FR2627985A1 (fr) Coadministration d'un medicament anti-inflammatoire non steroidique et de la sufotidine ou un de ses sels physiologiquement acceptables
US20050020657A1 (en) Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-2
TW206153B (da)
CN1179722C (zh) 含有星形细胞功能改进剂作为活性组分的帕金森氏病治疗剂
CA2341400A1 (en) Methods and compositions employing optically pure s(+) vigabatrin
JPH08506808A (ja) 呼吸障害治療用組成物の製造における鎮痛剤ｓ（＋）対掌体の利用
CN86100749A (zh) 制备改进的抗炎药剂的方法
CN1897956A (zh) 用于治疗肌纤维痛的方法和含有沙利度胺的组合物
EP1187606A1 (en) Pharmaceutical composition containing sibutramine and orlistat
LU85242A1 (fr) Nouvelle association medicamenteuse
BE1000265A3 (fr) Nouvelle association medicamenteuse.
FR2627986A1 (fr) Composition pharmaceutique a base de 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one ou d'un de ses sels et de dexamethasone, son procede de preparation et ses utilisations
FR2705569A1 (fr) Composition pharmaceutique à base d'une imidazolylcarbazolone destinée à l'administration rectale.
WO2019130049A1 (en) Pharmaceutical combination comprising extended-release tramadol hydrochloride and immediate-release etoricoxib, and its use for the treatment of pain
FR2512343A1 (fr) Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5- ( (3-( 3-1-piperidinylmethyl)phenoxy)propyl)amino)-1h-1,2,4-triazole-3-methanol ou un sel de ce compose acceptable pour l'usage pharmaceutique et procede de preparation de cette composition
FR2512342A1 (fr) Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose
JPH0680009B2 (ja) 抗高血圧組み合わせ医薬
CA2152280C (fr) Utilisation du riluzole comme radiorestaurateur

Legal Events

Date Code Title Description
ST Notification of lapse